A response to: Repeated intranasal ketamine for treatment resistant depression: The way to go? Results from a pilot randomised controlled trial

Vincent Lee¹, Shaina Archer¹, Carson Chrenek^{1

2}, Jennifer Swainson^{1

2}

Affiliations

Comment

Vincent Lee et al. J Psychopharmacol. 2019 Feb.

. 2019 Feb;33(2):258-259.

doi: 10.1177/0269881118822160.

Vincent Lee¹, Shaina Archer¹, Carson Chrenek^{1

2}, Jennifer Swainson^{1

2}

No abstract available

Comment in

A reply to comments by Lee and colleagues on: Repeated intranasal ketamine for treatment resistant depression - the way to go? Results from a pilot randomised controlled trial.
Gálvez Ortiz V, Glue P, Somogyi AA, Martin D, Alonzo A, Rodgers A, Mitchell PB, Li A, Huggins C, Loo CK. Gálvez Ortiz V, et al. J Psychopharmacol. 2019 Feb;33(2):260-261. doi: 10.1177/0269881118822147. J Psychopharmacol. 2019. PMID: 30773113 No abstract available.

Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial.
Gálvez V, Li A, Huggins C, Glue P, Martin D, Somogyi AA, Alonzo A, Rodgers A, Mitchell PB, Loo CK. Gálvez V, et al. J Psychopharmacol. 2018 Apr;32(4):397-407. doi: 10.1177/0269881118760660. Epub 2018 Mar 15. J Psychopharmacol. 2018. PMID: 29542371 Clinical Trial.